This is great obfuscation! All your links were to why some EU states were slow to roll out I haven't refuted this. Your last three paragraphs are to the matter at hand.The Paul Ehrlict Institute reported that Germany could also benefit from individual approval, as could a number of EU member states (apparently) so with all the frustrations, how come none of them enacted this?
Granted regulation 174 was UK specific, but the EMA left London in 2019, and although still technically representative along side the Medicines and Healthcare products Regulatory Agency, it was transitioned in everything but name until a week after the EU approved vaccines.
At very best, the UK and EU would have butted heads, and argued over the decision that went against EU policy during the time, which there had been plenty of examples of in recent history.
Did the UK have a faster rollout due to removal of EU red tape?
Paragraph 1 agrees with assertions (no link provided)
Paragraph 2 and 3 is your own conjecture. Considering my link was litreally just the first fact checking site Google found in a 5 second search. I'd have thought you have found some link refuting it explicitly from a reputable source in 30mins.
You didn't.
You have been playing Brexiteer Bingo you the weakest link goodbye.